Voltron Therapeutics
vaccine development
Based in NY
🤖
AI Overview
With $160K in lobbying spend across 20 quarterly filings, Voltron Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2025.
$160K
Total Spend
5
Years Active
1
Firms Hired
5
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $30K |
| 2022 | $40K |
| 2023 | $40K |
| 2024 | $20K |
| 2025 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Voltron Therapeutics disclosed contacting in their lobbying filings.
HOUSE OF REPRESENTATIVESSENATENatl Institutes of Health (NIH)Defense, Dept of (DOD)Health & Human Services, Dept of (HHS)
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
educating and advancing platform vaccine development
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.